# CELL SURFACE ANTIGENS ON HUMAN MACROPHAGES > **NIH NIH R01** · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 1989 · $210,411 ## Abstract The objective of this investigation is the study of human mononuclear phagocyte differentiation and function through the development of monoclonal reagents that identify membrane antigens expressed by monocytes, macrophages, granulocytes, and their precursors. Among the surface antigens identified thus far, Mol, a two-subunit glycoprotein (gp 155, 94) expressed by monocytes, neutrophils, and bone marrow myeloid precursors, has a clear functional significance. In antibody blocking studies, anti-Mol monoclonal antibodies specific for the 155 kilodalton alpha subunit inhibit the binding of C3bi-coated particles to human neutrophils and monocytes. The noncytotoxic enzyme release (histaminase, lysozyme, beta-glucuronidase) from neutrophils stimulated by C3biopsonized zymosan is also blocked by pretreatment of cells with anti-Mol Fab. These results suggest that the Mol-alpha is the C3bi receptor (CR3) on human myeloid cells. Mol may play a role in Fc-\and C3 receptor-dependent phagocytosis, since this function is also reduced in antibody blocking experiments. The functional significance of Mol is indicated by its deficient expression on two pediatric patients whose phagocytes exhibit functional defects that include impaired immune phagocytosis, opsonized zymosan-induced degranulation, and substrate spreading/adhesion. While Mol is a constituent plasma membrane glycoprotein, a large intracellular pool of Mol is associated with the specific granular fraction of neutrophils. After exposure of neutrophils to degranulating stimuli, this intracellular granule-associated Mol is translocated to the plasma membrane resulting in a 10-fold increase in surface Mol density. By this mechanism, neutrophils may rapidly increase available membrane receptor sites without the requirement of neosynthesis. In addition to the myelomonocytic markers Mol-Mo6 (see 1983 report), we have since developed additional monoclonal reagents that identify late macrophage-specific differentiation antigens (PAM1 and BMM1). BMM1 is a protease-sensitive two-subunit surface protein (p 40, 46) found on macrophages isolated from human colostrum, while PAM1 is a papain-sensitive 200 kilodalton polypeptide uniquely expressed by pulmonary alveolar macrophages. Neither antigen is found on peripheral blood monocytes or any other circulating or bone marrow cell. Thus, both antigens are highly restricted in their expression by mononuclear phagocytes found in distinct anatomical sites and provide additional evidence for the structural and functional heterogeneity displayed by cells within this lineage. (CS) ## Key facts - **NIH application ID:** 3177792 - **Project number:** 5R01CA039064-06 - **Recipient organization:** UNIVERSITY OF MICHIGAN AT ANN ARBOR - **SAM.gov UEI:** GNJ7BBP73WE9 - **Principal Investigator:** ROBERT F TODD - **Activity code:** R01 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 1989 - **Award amount:** $210,411 - **Award type:** 5 - **Project period:** 1984-07-01 → 1990-04-30 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/3177792 ## Citation > US National Institutes of Health, RePORTER application 3177792, CELL SURFACE ANTIGENS ON HUMAN MACROPHAGES (5R01CA039064-06). Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/grant/nih/3177792. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*